Welcome to the ICCS Website
The fundamental goal of the ICCS is to improve the quality of life and the life expectancy for all growing individuals with deficient bladder function, expressed as problems of storage and evacuation of urine. ICCS intends to approach this goal by increasing knowledge in all aspects of this problem area.
President's Message
Dear ICCS member
I am writing these lines on a windy Baltic see while returning by boat from the ICCS conference in Gdansk, Poland. The meeting was absolutely excellent. The scientific presentations were high quality, the atmosphere was friendly and the state of the art lectures made us all learn so much more. And it's so nice to belong to a scientific society in which the questions asked by the audience to the speakers are driven by curiosity, not ego. And the food was excellent. And I am proud to say that the Swedish team were real heroes at the dance floor. I want to thank Michal Maternik and his team for arranging such a memorable meeting........ More...
Abstract Deadline Extended to May 12, 2019
Registration form or registration on-line available at:
click on link to go to meeting website www.iccs2019.com
REGISTRATION FEES EARLY BIRD REGULAR ON SITE
ICCS Member Doctor 300 Euro 350 Euro 400 Euro
Non-Member Doctor 350 Euro 400 Euro 450 Euro
Nurse/Physiotherapist 250 Euro 300 Euro 350 Euro
Urodynamics /Urotherapy course 50 Euro 75 Euro 100 Euro
Organizers:
Michał Maternik
Department of Pediatrics, Nephrology and Hypertension
Medical University of Gdansk
Rafal Chrzan
Department of Pediatric Urology
Jagiellonian University in Krakow
ICCS Annual Meeting Office:
Michał Faliński
KOMBINAT Spółka z ograniczoną odpowiedzialnością Sp. k.
mfalinski@grupakombinat.pl
+ 48 600 800 916
Industry cooperation statement
The ICCS is an independent, nonprofit organisation aimed at the advancement of research and healthcare. The ICCS Board and associated experts get no payment for their work. The running costs of the ICCS are covered by membership fees and unconditional educational grants from the medical industry.
Foremost among the latter are presently two companies: Ferring Pharmaceuticals and Coloplast, the cooperation with which we hereby gratefully acknowledge. The cooperation is regulated by contracts guaranteeing the independence and protection of both parts, and all matters of common interest are handled by liaison committees, with members from the ICCS and the two companies.
The ICCS members of the ICCS-Ferring liaison committee are Janet Chase, Søren Rittig and Johan Vande Walle. The ICCS members of the ICCS-Coloplast liaison committee are Mario De Gennaro, Søren Rittig and Anka Nieuwhof-Leppink.